IFNG and neoplasm: It was shown that 2DG treatment of T cells during activation can reduce IFN-γ secretion in vitro [46,50,51,52] and in rodent models in vivo [53,54,55], suggesting that 2DG could adversely affect the IFN-γ production in the context of the anti-tumor immune response.